Amalgamated Bank Jazz Pharmaceuticals PLC Transaction History

Amalgamated Bank

  • $13.6 Billion
  • Q3 2025

A detailed history of Amalgamated Bank transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Amalgamated Bank holds 27,572 shares of JAZZ stock, worth $3.67 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,572
Previous 28,013 1.57%
Holding current value
$3.67 Million
Previous $2.97 Million 22.24%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025
SELL
$105.93 - $131.8 $46,715 - $58,123
-441 Reduced 1.57%
27,572 $3.63 Million
Q2 2025

Aug 04, 2025
BUY
$97.78 - $126.44 $41,752 - $53,989
427 Added 1.55%
28,013 $2.97 Million
Q1 2025

Apr 25, 2025
SELL
$120.07 - $144.17 $146,125 - $175,454
-1,217 Reduced 4.23%
27,586 $3.43 Million
Q4 2024

Feb 04, 2025
SELL
$107.32 - $127.74 $68,792 - $81,881
-641 Reduced 2.18%
28,803 $3.55 Million
Q3 2024

Oct 30, 2024
SELL
$100.57 - $116.37 $973,618 - $1.13 Million
-9,681 Reduced 24.74%
29,444 $3.28 Million
Q2 2024

Aug 12, 2024
BUY
$103.94 - $118.98 $181,375 - $207,620
1,745 Added 4.67%
39,125 $4.18 Million
Q1 2024

Apr 23, 2024
SELL
$115.19 - $132.77 $408,809 - $471,200
-3,549 Reduced 8.67%
37,380 $4.5 Million
Q4 2023

Feb 06, 2024
SELL
$114.26 - $136.0 $100,206 - $119,272
-877 Reduced 2.1%
40,929 $5.03 Million
Q3 2023

Nov 08, 2023
SELL
$122.0 - $145.31 $201,056 - $239,470
-1,648 Reduced 3.79%
41,806 $5.41 Million
Q2 2023

Aug 11, 2023
BUY
$122.5 - $147.16 $52,920 - $63,573
432 Added 1.0%
43,454 $5.39 Million
Q1 2023

May 02, 2023
SELL
$133.98 - $160.47 $353,707 - $423,640
-2,640 Reduced 5.78%
43,022 $6.3 Million
Q4 2022

Feb 10, 2023
BUY
$129.72 - $159.85 $64,211 - $79,125
495 Added 1.1%
45,662 $7.27 Million
Q3 2022

Nov 09, 2022
BUY
$126.59 - $161.18 $178,238 - $226,941
1,408 Added 3.22%
45,167 $6.02 Million
Q2 2022

Aug 15, 2022
BUY
$141.59 - $168.66 $207,995 - $247,761
1,469 Added 3.47%
43,759 $6.83 Million
Q1 2022

Jun 30, 2022
SELL
$129.64 - $160.7 $192,515 - $238,639
-1,485 Reduced 3.39%
42,290 $6.58 Million
Q4 2021

Feb 15, 2022
SELL
$119.87 - $145.67 $183,401 - $222,875
-1,530 Reduced 3.38%
43,775 $5.58 Million
Q3 2021

Oct 29, 2021
SELL
$128.64 - $184.79 $494,234 - $709,963
-3,842 Reduced 7.82%
45,305 $5.9 Million
Q2 2021

Aug 16, 2021
BUY
$160.2 - $186.42 $6.77 Million - $7.88 Million
42,276 Added 615.28%
49,147 $8.73 Million
Q1 2021

May 13, 2021
SELL
$150.19 - $173.5 $50,614 - $58,469
-337 Reduced 4.68%
6,871 $1.13 Million
Q4 2020

Feb 12, 2021
BUY
$140.71 - $165.05 $2,954 - $3,466
21 Added 0.29%
7,208 $1.19 Million
Q3 2020

Oct 30, 2020
BUY
$105.46 - $144.13 $47,457 - $64,858
450 Added 6.68%
7,187 $1.03 Million
Q2 2020

Aug 10, 2020
SELL
$95.68 - $121.88 $710,232 - $904,715
-7,423 Reduced 52.42%
6,737 $743,000
Q1 2020

May 13, 2020
SELL
$87.74 - $152.74 $28,164 - $49,029
-321 Reduced 2.22%
14,160 $1.41 Million
Q4 2019

Feb 13, 2020
BUY
$117.65 - $153.73 $88,119 - $115,143
749 Added 5.45%
14,481 $2.16 Million
Q3 2019

Nov 13, 2019
BUY
$125.18 - $143.24 $201,915 - $231,046
1,613 Added 13.31%
13,732 $1.76 Million
Q2 2019

Aug 14, 2019
SELL
$125.55 - $144.48 $140,867 - $162,106
-1,122 Reduced 8.47%
12,119 $1.73 Million
Q1 2019

May 15, 2019
BUY
$121.81 - $142.95 $30,817 - $36,166
253 Added 1.95%
13,241 $1.89 Million
Q4 2018

Feb 15, 2019
BUY
$115.94 - $166.74 $542,599 - $780,343
4,680 Added 56.33%
12,988 $1.61 Million
Q3 2018

Nov 14, 2018
SELL
$161.01 - $180.57 $839,667 - $941,672
-5,215 Reduced 38.56%
8,308 $1.4 Million
Q2 2018

Jul 18, 2018
BUY
$146.33 - $183.18 $1.98 Million - $2.48 Million
13,523 New
13,523 $2.33 Million

Others Institutions Holding JAZZ

# of Institutions
569
Shares Held
62.1M
Call Options Held
563K
Put Options Held
79.8K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.35B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email